Skip to main content
SpringerLink
Log in

Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension

  • Science Letters
  • Published:
Journal of Zhejiang University SCIENCE B Aims and scope Submit manuscript

Abstract

Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease of unknown etiology. The exact pathogenesis of pulmonary arterial hypertension is still not well known. In the past decades, many protein molecules have been found to be involved in the development of IPAH. With proteomic techniques, profiling of human plasma proteome becomes more feasible in searching for disease-related markers. In present study, we showed the protein expression profiles of the serum of IPAH and healthy controls after depleting a few high-abundant proteins in serum. Thirteen spots had changed significantly in IPAH compared with healthy controls and were identified by LC-MS/MS. Alpha-1-antitrypsin and vitronectin were down-regulated in IPAH and may be valuable candidates for further explorations of their roles in the development of IPAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abdul-Salam, V.B., Paul, G.A., Ali, J.O., Gibbs, S.R., Rahman, D., Taylor, G.W., Wilkins, M.R., Edwards, R.J., 2006. Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics, 6(7):2286–2294. [doi:10.1002/pmic.200500510]

    Article  PubMed  CAS  Google Scholar 

  • Anderson, N.L., Anderson, N.G., 2002. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics, 1(11):845–867. [doi:10.1074/mcp.R200007-MCP200]

    Article  PubMed  CAS  Google Scholar 

  • Arrell, D.K., Elliott, S.T., Kane, L.A., Guo, Y., Ko, Y.H., Pedersen, P.L., Robinson, J., Murata, M., Murphy, A.M., Marban, E., van Eyk, J.E., 2006. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ. Res., 99(7):706–714. [doi:10.1161/01.RES.0000243995.74395.f8]

    Article  PubMed  CAS  Google Scholar 

  • Bezstarosti, K., Das, S., Lamers, J.M., Das, D.K., 2006. Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol. J. Cell Mol. Med., 10(4):896–907.

    PubMed  Google Scholar 

  • Brantly, M., Nukiwa, T., Crystal, R.G., 1988. Molecular basis of alpha-1-antitrypsin deficiency. Am. J. Med., 84(6A): 13–31. [doi:10.1016/0002-9343(88)90154-4]

    PubMed  Google Scholar 

  • Cowan, K.N., Heilbut, A., Humpl, T., Lam, C., Ito, S., Rabinovitch, M., 2000. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat. Med., 6(6):698–702. [doi:10.1038/76282]

    Article  PubMed  CAS  Google Scholar 

  • Deng, Z.M., Morse, J.H., Slager, S.L., Cuervo, N., Moore, K.J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S.G., Barst, R.J., Hodge, S.E., Knowles, J.A., 2000. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet., 67(3):737–744. [doi:10.1086/303059]

    Article  PubMed  CAS  Google Scholar 

  • Echan, L.A., Tang, H.Y., Ali-Khan, N., Lee, K., Speicher, D.W., 2005. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics, 5(13):3292–3303. [doi:10.1002/pmic.200401228]

    Article  PubMed  CAS  Google Scholar 

  • Fay, W.P., Parker, A.C., Ansari, M.N., Zheng, X.X., Ginsburg, D., 1999. Vitronectin inhibits the thrombotic response to arterial injury in mice. Blood, 93(6):1825–1830.

    PubMed  CAS  Google Scholar 

  • Gallego-Delgado, J., Lazaro, A., Osende, J.I., Esteban, V., Barderas, M.G., Gomez-Guerrero, C., Vega, R., Vivanco, F., Egido, J., 2006. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. J. Am. Soc. Nephrol., 12(12 Suppl. 3):S159–164. [doi:10.1681/ASN.2006080937]

    Article  Google Scholar 

  • Giaid, A., Saleh, D., 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med., 333(4):214–221. [doi:10.1056/NEJM199507273330403]

    Article  PubMed  CAS  Google Scholar 

  • Huber, K., Beckmann, R., Frank, H., Kneussl, M., Mlczoch, J., Binder, B.R., 1994. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension. Am. J. Respir. Crit. Care Med., 150(4):929–933.

    PubMed  CAS  Google Scholar 

  • Humbert, M., Sitbon, O., Simonneau, G., 2004. Treatment of pulmonary artery hypertension. N. Engl. J. Med., 351(14): 1425–1436. [doi:10.1056/NEJMra040291]

    Article  PubMed  CAS  Google Scholar 

  • Lane, K.B., Machado, R.D., Pauciulo, M.W., Thomson, J.R., Phillips, J.A., Loyd, J.E., Nichols, W.C., Trembath, R.C., 2000. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension: the international PPH consortium. Nat. Genet. 26(1):81–84. [doi:10.1038/79226]

    Article  PubMed  CAS  Google Scholar 

  • Li, H., Xiao, Y.B., Gao, Y.Q., Yang, T.D., 2006. Comparative proteomics analysis of differentially expressed phosphoproteins in adult rat ventricular myocytes subjected to diazoxide preconditioning. Drug Metabol. Drug Interact., 21(3–4):245–258.

    PubMed  Google Scholar 

  • Lomas, D.A., Mahadeva, R., 2002. Alpha 1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J. Clin. Invest., 110(11):1585–1590. [doi:10.1172/JCI200216782]

    Article  PubMed  CAS  Google Scholar 

  • Machado, R.D., Pauciulo, M.W., Thomson, J.R., Lane, K.B., Morgan, N.V., Wheeler, L., Phillips, J.A., Newman, J., Williams, D., Galie, N., et al., 2001. BMPR2 haploin-sufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am. J. Hum. Genet., 68(1):92–102. [doi:10.1086/316947]

    Article  PubMed  CAS  Google Scholar 

  • Mayasundari, A., Whittemore, N.A., Serpersu, E.H., Peterson, C.B., 2004. The solution structure of the N-terminal domain of human vitronectin. J. Biol. Chem., 279(28):29359–29366. [doi:10.1074/jbc.M401279200]

    Article  PubMed  CAS  Google Scholar 

  • Napoli, C., Loscalzo, J., 2004. Nitric oxide and other novel therapies for pulmonary hypertension. J. Cardiovasc. Pharmacol. Ther., 9(1):1–8.

    PubMed  CAS  Google Scholar 

  • Okano, T., Kondo, T., Kakisaka, T., Fujii, K., Yamada, M., Kato, H., Nishimura, T., Gemma, A., Kudoh, S., Hirohashi, S., 2006. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics, 6(13):3938–3948. [doi:10.1002/pmic.200500883]

    Article  PubMed  CAS  Google Scholar 

  • Petrache, I., Fijalkowska, I., Medler, T.R., Skirball, J., Cruz, P., Zhen, L., Petrache, H.I., Flotte, T.R., Tuder, R.M., 2006. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol., 169(4): 1155–1166. [doi:10.2353/ajpath.2006.060058]

    Article  PubMed  CAS  Google Scholar 

  • Pieper, R., Gatlin, C.L., Makusky, A.J., Russo, P.S., Schatz, C.R., Miller, S.S., Su, Q., McGrath, A.M., Estock, M.A., Parmar, P.P., et al., 2003. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics, 3(7):1345–1364. [doi:10.1002/pmic.200300449]

    Article  PubMed  CAS  Google Scholar 

  • Preissner, K.T., Seiffert, D., 1998. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb. Res., 89(1):1–21. [doi:10.1016/S0049-3848(97)00298-3]

    Article  PubMed  CAS  Google Scholar 

  • Price, D.T., Loscalzo, J., 1999. Cellular adhesion molecules and atherogenesis. Am. J. Med., 107(1):85–97. [doi:10.1016/S0002-9343(99)00153-9]

    Article  PubMed  CAS  Google Scholar 

  • Reheman, A., Gross, P., Yang, H., Chen, P., Allen, D., Leytin, V., Freedman, J., Ni, H., 2005. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J. Thromb. Haemost., 3(5):875–883. [doi:10.1111/j.1538-7836.2005.01217.x]

    Article  PubMed  CAS  Google Scholar 

  • Teichert-Kuliszewska, K., Kutryk, M.J.B., Kuliszewski, M.A., Karoubi, G., Courtman, D.W., Zucco, L., Granton, J., Stewart, D.J., 2006. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival. Circ. Res., 98(2):209–217. [doi:10.1161/01.RES.0000200180.01710.e6]

    Article  PubMed  CAS  Google Scholar 

  • Teixeira, P.C., Iwai, L.K., Kuramoto, A.C., Honorato, R., Fiorelli, A., Stolf, N., Kalil, J., Cunha-Neto, E., 2006. Proteomic inventory of myocardial proteins from patients with chronic Chagas’ cardiomyopathy. Braz. J. Med. Biol. Res., 39(12):1549–1562. [doi:10.1590/S0100-879X2006001200005]

    Article  PubMed  CAS  Google Scholar 

  • Tomasini, B.R., Mosher, D.F., 1990. Vitronectin. Prog. Hemostas. Thromb., 10(2):269–305.

    Google Scholar 

  • Tuder, R.M., Cool, C.D., Yeager, M., Taraseviciene-Stewart, L., Bull, T.M., Voelkel, N.E., 2001. The pathobiology of pulmonary hypertension. Endothelium. Clin. Chest Med., 22(3):405–418. [doi:10.1016/S0272-5231(05)70280-X]

    Article  PubMed  CAS  Google Scholar 

  • Zhao, Y.D., Courtman, D.W., Deng, Y.P., Kugathasan, L., Zhang, Q.W., Stewart, D.J., 2005. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells. Efficacy of combined cell and eNOS gene therapy in established disease. Circ. Res., 96(4):442–450. [doi:10.1161/01.RES.0000157672.70560.7b]

    Article  PubMed  CAS  Google Scholar 

  • Zhuang, P., Blackburn, M.N., Peterson, C.B., 1996. Characterization of the denaturation and renaturation of human plasma vitronectin: I. Biophysical characterization of protein unfolding and multimerization. J. Biol. Chem., 271(24):14323–14332. [doi:10.1074/jbc.271.24.14323]

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China

    Yu Min, Wang Xing-xiang, Zhang Fu-rong, Shang Yun-peng, Chen Hong-juan & Chen Jun-zhu

  2. Department of Cardiovascular Disease, Taizhou Hospital, Taizhou, 317000, China

    Du Yu-xi

Authors
  1. Yu Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wang Xing-xiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhang Fu-rong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shang Yun-peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Du Yu-xi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chen Hong-juan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chen Jun-zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chen Jun-zhu.

Additional information

Project (No. A-007) supported by the Key Medicine Foundation of Zhejiang Province, China

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, M., Wang, Xx., Zhang, Fr. et al. Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension. J. Zhejiang Univ. - Sci. B 8, 221–227 (2007). https://doi.org/10.1631/jzus.2007.B0221

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.2007.B0221

Key words

CLC number

Search

Navigation